10x Genomics, Inc. TXG Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s total liabilities & equity?
- 10x Genomics, Inc. (TXG) reported total liabilities & equity of $1.02B in Q1 2026.
- How has 10x Genomics, Inc.'s total liabilities & equity changed year-over-year?
- 10x Genomics, Inc.'s total liabilities & equity increased by 12.4% year-over-year, from $903.39M to $1.02B.
- What is the long-term trend for 10x Genomics, Inc.'s total liabilities & equity?
- Over 5 years (2020 to 2025), 10x Genomics, Inc.'s total liabilities & equity has grown at a 2.3% compound annual growth rate (CAGR), from $929.34M to $1.04B.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.